HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Avon To Exit South Korea and Vietnam, Cut 1,500 Positions Globally

This article was originally published in The Rose Sheet

Executive Summary

In an effort to realize $400 million in annual cost savings by 2015, Avon plans to eliminate part of its workforce and withdraw from two Asian markets.

You may also be interested in...



CEO McCoy: Avon Q3 “Disappointing,” But Focus Is On Future

After posting third-quarter profits of $31.6 million, down 81%, Avon announces a cost savings plan aimed at saving the firm $400 million over three years. CEO Sheri McCoy was upbeat about Avon’s prospects, but acknowledged that financial troubles would not be resolved by “a magic bullet or quick fix.”

Korea Can Serve As “Market Laboratory” For Beauty Firms In Asia

U.S.-based brands including Procter & Gamble and L’Oreal are leveraging the wealth and trend-setting influence of residents of South Korean capital Seoul to test new personal care products.

Euromonitor: Value Shopping, Gender-Blurring Among Top Consumer Trends For 2106

A new report from market-research firm Euromonitor International suggests that global consumption in the coming year will see a blend of established, new and counter trends, challenging the way consumers live and shop. Within beauty, marketers may seize on the trends of value shopping, gender-blurring and embracing of aging to reach discriminating consumers in 2016.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018403

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel